Prof. Dr. Esmaeil Babaei , University of Tabriz, Iran
Professor Esmaeil Babaei is a distinguished molecular geneticist specializing in human cancer genetics and bioinformatics. With over 13 years of post-PhD experience, he serves as a Full Professor at the School of Natural Sciences, University of Tabriz, Iran. His research focuses on cancer biomarkers, gene expression, and nano-based therapeutics. Prof. Babaei has authored 95 research papers, two book chapters, and supervised numerous PhD and MSc students. As a principal investigator of multiple national and international projects, he has contributed to biotech innovations, including the Covid-19 PCR kit and nanocurcumin-based cancer therapy. 🌍🔬
Professional Profile:
Google Scholar
Suitability for Best Researcher Award 🏆
Professor Esmaeil Babaei is a highly deserving candidate for the Best Researcher Award due to his outstanding contributions to molecular genetics, cancer research, and bioinformatics. With over 13 years of post-PhD experience, he has made significant advancements in cancer biomarker discovery, nano-based therapeutics, and biotech innovations. His extensive publication record (95 research papers, two book chapters), leadership roles, and international collaborations further reinforce his suitability.
Education 🎓
-
PhD in Molecular Genetics – Tarbiat Modares University, Tehran, Iran (2007–2012) 🧪
-
MSc in Molecular Genetics – Tarbiat Modares University, Tehran, Iran (2002–2005) 🧬
-
BSc in Biology – Shahid Beheshti University, Tehran, Iran (1998–2002) 🏛️
Experience 🏢
-
Full Professor – University of Tabriz (2021–Present) 👨🏫
-
Associate Professor – University of Tabriz (2016–2021) 🔬
-
Assistant Professor – University of Tabriz (2012–2016) 🧑🎓
-
Guest Scientist – University of Tübingen, Germany (2023) 🇩🇪Guest Scientist – University of Salzburg, Austria (2017, 2011) 🇦🇹
Professional Development & Leadership 🌟
Prof. Esmaeil Babaei has played a significant role in advancing biotech-based innovations and cancer research. As a member of the board of directors at the Iranian Genetics Society, he has contributed to shaping genetic research policies. He also serves as an editorial board member of Frontiers publications and is a joint professor at the College of Pharmacy, Hawler Medical University, Iraq. His extensive peer-review contributions span reputed journals like Oncogene, Scientific Reports, and Phytomedicine. As the former Head of the Central Lab atthe University of Tabriz, he was instrumental in establishing stem cell and biotechnology facilities. 🔬📚
Research Focus 🔍
Prof. Babaei’s research encompasses molecular oncology, bioinformatics, and nanomedicine. His groundbreaking work includes nanozymeassisted CRISPR/Cas systems for food safety, miRNA biosensing, and biomarker discovery. He has pioneered RNA sequencing and transcriptome analysis for cancer diagnostics. His innovations, such as the Curcuden35 nanocurcumin capsule, demonstrate his expertise in targeted drug delivery and anticancer therapeutics. His contributions to biotechnological advancements extend to genomic data analysis, microRNA-target studies, and cancer gene expression profiling. 🧬🔬💊
Awards & Honors 🏆
-
Best International Researcher Award – University of Tabriz (2024) 🏅
-
Best Research Award – Faculty of University of Tabriz (2023) 🏆
-
DFG Research Grant – RNA sequencing training in Germany (2021) 🇩🇪
-
Best Teacher’s Award – University of Tabriz (2019) 🎓
-
Annual Biotechnology Award – CurcuDen35 nano formulation (2015) 🧪
-
Young Investigator Award – 8th INCTR Congress, Turkey (2009) 🎖️
-
1st Rank in PhD Entrance Exam – Tarbiat Modares University (2006) 🎓
-
Iran’s National Olympiad in Biology Selection – (2002) 🏅
Publication Top Notes:
📄 “Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo”
📄 “Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells” – 📑 Cited by: 152
📄 “MgrB Alterations Mediate Colistin Resistance in Klebsiella pneumoniae Isolates from Iran” – 📑 Cited by: 113
📄 Curcumin-based nanoformulations: A promising adjuvant towards cancer treatment” – 📑 Cited by: 86
📄 “The anti-proliferative and apoptotic effects of crocin on chemosensitive and chemoresistant cervical cancer cells” – 📑 Cited by: 71
📄 “Dendrosomal nano-curcumin, the novel formulation to improve the anticancer properties of curcumin” – 📑 Cited by: 62